US Stock MarketDetailed Quotes

Intellia Therapeutics (NTLA)

Watchlist
  • 11.870
  • -0.150-1.25%
Close Jan 15 16:00 ET
  • 12.060
  • +0.190+1.60%
Pre 05:05 ET
1.37BMarket Cap-2.79P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Intellia Therapeutics (NTLA) Revenue Breakdown Overview

By Business/Source

Currency:USD
2025/Q3
Stock NameRevenueRatio
Development of genome editing-based therapies13.78M100.00%

By Country/Region

Currency:USD
2024/FY
Stock NameRevenueRatio
United States57.88M100.00%
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -